5-benzyloxytryptamine [263]
5-benzyloxytryptamine
| SMILES | NCCc1c[nH]c2ccc(OCc3ccccc3)cc12 |
| InChIKey | WKPDXBXNJWWWGQ-UHFFFAOYSA-N |
Chemical Properties
| Hydrogen bond acceptors | 2 |
| Hydrogen bond donors | 2 |
| Rotatable bonds | 5 |
| Log P | 3.248 |
| Molecular weight (Da) | 266.1 |
| Stereochemistry info | unspecified |
Database connections
| Ligand site mutations | 5-HT6 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
5-benzyloxytryptamine
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Ligand site mutations | 5-HT6 |